COVID-19 Vaccine Development Using New, Fast-Growing Tobacco Plant TechnologyApril 22, 2020
British American Tobacco (BAT) has joined the race in developing a potential vaccine for COVID-19 using a new, fast-growing tobacco plant technology. BAT's biotech subsidiary in the United States, Kentucky BioProcessing (KBP), is developing the potential vaccine for COVID-19 and is now in pre-clinical testing. BAT and KBP work closely with the U.S. Food and Drug Administration (FDA), U.S. Biomedical Advanced Research and Development Authority (BARDA), and the United Kingdom's Department for Health and Social Care.
In an interview on Ian King Live on Sky News in the UK, BAT's Chief Marketing Officer Kingsley Wheaton said that their work on the potential vaccine is carried out on a not-for-profit basis. KBP has cloned a portion of COVID-19's genetic sequence which led to the development of a potential antigen. The antigen was then inserted into tobacco plants for reproduction. Upon harvest, the antigen was purified and is now undergoing pre-clinical testing.
The potential vaccine in development uses BAT's proprietary, fast-growing tobacco plant technology which has several advantages over conventional vaccine production technology. It is potentially safer as tobacco plants cannot host pathogens causing human diseases. It is also faster because the elements of the vaccine accumulate in tobacco plants much more quickly – 6 weeks in tobacco plants versus several months using conventional methods. The vaccine formulation in development remains stable at room temperature, unlike conventional vaccines which often require refrigeration. Lastly, it has the potential to deliver an effective immune response in a single dose.
For more details, read the news release from BAT.
You might also like:
- Researchers in Spain Use Biotech to Produce SARS-CoV-2 Vaccine in Plants
- Native Australian Plant Paves Way for Vaccine Development Against COVID-19
- Viable Vaccine Candidate for COVID-19 Developed Using Proprietary Plant-based Technology
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- COVID-19 Vaccine Development Using New, Fast-Growing Tobacco Plant Technology
- A Call to Action for World Leaders: Prevent Global Food Security Crisis in COVID-19 Fight
News from Around the World
- Science Speaks, ISAAA's Blog is Now Up!
- GE Crops Yielded Massive Economic and Environmental Benefits
- Effective Science Communication Goes Beyond Communicating Science, Arujanan Says
- Researchers Discover Longevity Gene in Plants
- International Team Completes Study on Cotton Genomics to Improve Cotton Varieties
- Experts Report an Improved Soybean Transformation Method
Plant Breeding Innovations
- Researchers to Improve Berries Using CRISPR Technology
- Argentina's Years of Experience in Gene Editing Regulation
Read the latest:
- Crop Biotech Update (November 23, 2022)
- Genome Editing Supplement (November 23, 2022)
- Gene Drive Supplement (October 26, 2022)
Subscribe to CBU: